IBM Common Stock (IBM) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

IBM Common Stock (IBM)

223.65

+1.91 (0.86%)

as of Jul 31, 2026, 8:00:00 pm Market Open.

277 watching

Investor Insights

Jul 31, 2026, 12:00 am

This summary was created by AI, based on 26 opinions in the last 12 months.

IBM's recent performance has been mixed, highlighted by significant stock fluctuations and earnings surprises. While some analysts noted a severe drop in share price following earnings, with concerns about execution slips and high valuations, others pointed to the company's strengths, including its robust AI and quantum computing initiatives. The stock's current price levels seem volatile, with predictions of further declines unless stabilization occurs around key support levels. Despite the potential for growth driven by AI and software services, and recent strong earnings reports, there remain skeptics who believe IBM's valuation may be overstated given current market dynamics. Overall, the outlook varies widely among experts, reflecting both the challenges and opportunities the company faces in a competitive landscape.

Consensus

Hold

Valuation

Fair Value

Similar

MSFT

DON'T BUY

Doesn't particularly like. Has never owned. Well behind the top players in the cloud. Not strong revenue growth. Grown bottom line only by buying back shares. In tech, you want to be in something that's growing and compounding at a better rate.

Wealthica Track your Stocks in your Watch List

WATCH

It has been a restructure play for a number of years now. Cheap in technology is a dangerous issue sometimes because it can mean no growth. It is always on his radar screen. Others are more attractive in the short term.

COMMENT

They report Monday. The stock has been hanging in there and lately older tech names have been strong like Dell. Maybe IBM joins them.

RISKY

A trade, not an investment. Buy around $120, sell around $140. Hard to see a clear investment thesis on it, though it tries very hard. Legacy hardware side that they pull around like a ball and chain.

SELL

Allan Tong’s Discover Picks IBM stock was pounded nearly 10% after it released a harsh quarterly report where total sales declined for the fourth-straight report across all five of its business segments. For example, its systems business plunged 17.8% while net sales slid 6.5%. There's still hope that IBM's hybrid cloud business will pay off, after the company bought Red Hat in 2019. Read Hit and Misses: 5 Tempting Tech Stocks for our full analysis.

COMMENT

Will introduce the new management team next week. Their moderate growth, big dividend story could attract conservative investors.

DON'T BUY

Lagged higher growth areas since at least 2017. Yield is great at 5.1%. A tech company with high yield signals to him that growth is starting to stall. Be cautious. Cheap for a reason. Revenue growth looks anemic. Fine for income, not for growth.

PAST TOP PICK

(A Top Pick Oct 08/19, Down 10%) He sold most in June but holds it in his income portfolio. It was a turn around and he hoped the company would be turned around but he moved on when that thesis was washed out.

COMMENT

IBM vs. CSCO Cisco missed the boat on cloud, not a great growth rate, revenue's down, nice dividend. For dividends, likes IBM better as its risk/reward is better.

RISKY

Change in leadership, and jury's still out. A trade, more than an investment.12-month target of $129. Buy around $100-105, sell around $125-130.

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK

(A Top Pick Aug 20/20, Down 6.6%)Stockchase Research Editor: Michael O'Reilly We are being disciplined and recommending to cover holdings in IBM after breaching the $115 stop-loss level. Although the company continues to make strides in developing its cloud based business, we see other better opportunities to pursue.

BUY

It may be their time to shine. When they spin off their cloud division, they may have it growing at 30% a year. He expects earnings tonight to be the start of good things before they split up. They are spinning out their legacy divisions.

HOLD

Dead money for several years. Underappreciated story. Modeling 12% EPS growth. Compelling price to book. Nice dividend. Margins high last quarter. Beat on top line and bottom line. Get paid to wait. Not a great deal of risk.

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Stockchase Research Editor: Michael O'Reilly The company doesn't leap to mind as a up and coming rising star, but it is a dividend aristocrat with a strong, and sustainable, dividend. The company is expanding its efforts in AI and cloud based services, including a recent partnership in Korea, where citizens will share health related surveys for policy makers. The company was recently upgraded to a target of $155 -- over 25% upside potentially. We would trade this with a stop loss at $115. Yield 5.26% (Analysts’ price target is $134.06)

COMMENT

The granddaddy of US tech stocks, but didn't adapt well to the digital age. It's had declining sales, though remains profitable. Not a growth stock. But it pays a safe 5% dividend.

Showing 121 to 135 of 450 entries

Most Recent Experts

Amy Raskin, CIO, Chevy Chase Trust

Chevy Chase Trust

Stephanie Link, Chief investment strategist, Hightower

Hightower

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Jim Lebenthal

Cerity Partners

Brianne Gardner

Raymond James

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

IBM Common Stock (IBM)